Skip to main content
SpringerLink
Log in

ESC/EACTS-Leitlinie zur Revaskularisation des Myokards

Veränderungen 2014

ESC/EACTS guidelines on myocardial revascularization

Amendments 2014

  • Schwerpunkt
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

Eines der wichtigsten Behandlungsprinzipien in der Kardiologie ist die myokardiale Revaskularisierung entweder durch eine perkutane Koronarintervention oder durch eine Bypass-Operation. Um diese Behandlungsprinzipien effektiv einzusetzen, ist es erforderlich, die Patienten zu identifizieren, bei denen eine Revaskularisierung erforderlich ist. Ebenso ist die Auswahl der geeigneten Revaskularisationsmethode von entscheidender Bedeutung. Nur dann wird der größtmögliche Nutzen ohne Gefährdung des Patienten erzielt. In den neuen ESC/EACTS-Leitlinien zur myokardialen Revaskularisierung ergeben sich einige klinisch relevante neue Aspekte, die in dieser Übersicht zusammengefasst werden.

Abstract

One of the most important treatment principles in interventional cardiology relies on myocardial revascularization by percutaneous coronary intervention (PCI) or surgical placement of coronary artery bypass grafts (CABG). However, in order to apply these principles effectively, it is important to identify patients who require revascularization. Consequently, the appropriate method has to be selected to effectively restore blood flow. Patients will only benefit from the interventional or surgical procedures when those revascularization measures that can cause more harm than good are avoided. In the new European Society of Cardiology and European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization some new aspects will be addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Nabel EG, Braunwald E (2012) A tale of coronary artery disease and myocardial infarction. N Engl J Med 366:54–63

    Article  CAS  PubMed  Google Scholar 

  2. Fuster V, Mearns BM (2009) The CVD paradox: mortality vs prevalence. Nat Rev Cardiol 6:669

    Article  PubMed  Google Scholar 

  3. Olearchyk AS (1988) Vasilii I. Kolesov. A pioneer of coronary revascularization by internal mammary-coronary artery grafting. J Thorac Cardiovasc Surg 96:13–18

    CAS  PubMed  Google Scholar 

  4. Garrett HE, Dennis EW, DeBakey ME (1973) Aortocoronary bypass with saphenous vein graft. Seven-year follow-up. JAMA 223:792–794

    Article  CAS  PubMed  Google Scholar 

  5. Gruentzig A (1978) Transluminal dilatation of coronary-artery stenosis. Lancet 1:263

    Article  Google Scholar 

  6. Fox KA, Clayton TC, Damman P et al (2010) Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol 55:2435–2445

    Article  PubMed  Google Scholar 

  7. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20

    Article  PubMed  Google Scholar 

  8. Windecker S, Stortecky S, Stefanini GG et al (2014) Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 348:g3859

    Article  PubMed Central  PubMed  Google Scholar 

  9. Stefanini GG, Holmes DR Jr (2013) Drug-eluting coronary-artery stents. N Engl J Med 368:254–265

    Article  CAS  PubMed  Google Scholar 

  10. Windecker S, Kolh P, Alfonso F et al (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619

    Article  PubMed  Google Scholar 

  11. Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555

    Article  PubMed  Google Scholar 

  12. Head SJ, Kaul S, Mack MJ et al (2013) The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur Heart J 34:2510–2518

    Article  PubMed  Google Scholar 

  13. Shahian DM, O’Brien SM, Filardo G et al (2009) The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3 – valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 88:S43–S62

    Article  PubMed  Google Scholar 

  14. Shahian DM, O’Brien SM, Filardo G et al (2009) The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 – coronary artery bypass grafting surgery. Ann Thorac Surg 88:S2–S22

    Article  PubMed  Google Scholar 

  15. Nashef SA, Roques F, Sharples LD et al (2012) EuroSCORE II. Eur J Cardiothorac Surg 41:734–744

    Article  PubMed  Google Scholar 

  16. Biancari F, Vasques F, Mikkola R et al (2012) Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery. Ann Thorac Surg 93:1930–1935

    Article  PubMed  Google Scholar 

  17. Chalmers J, Pullan M, Fabri B et al (2013) Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur J Cardiothorac Surg 43:688–694

    Article  PubMed  Google Scholar 

  18. Siregar S, Groenwold RH, Heer F de et al (2012) Performance of the original EuroSCORE. Eur J Cardiothorac Surg 41:746–754

    Article  PubMed  Google Scholar 

  19. Hickey GL, Grant SW, Murphy GJ et al (2013) Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. Eur J Cardiothorac Surg 43:1146–1152

    Article  PubMed Central  PubMed  Google Scholar 

  20. Mohr FW, Rastan AJ, Serruys PW et al (2011) Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg 141:130–140

    Article  PubMed  Google Scholar 

  21. Mohr FW, Morice MC, Kappetein AP et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381:629–638

    Article  PubMed  Google Scholar 

  22. Genereux P, Palmerini T, Caixeta A et al (2011) SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv 4:553–561

    Article  PubMed  Google Scholar 

  23. Farooq V, Vergouwe Y, Raber L et al (2012) Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J 33:3098–3104

    Article  PubMed  Google Scholar 

  24. Farooq V, Klaveren D van, Steyerberg EW et al (2013) Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381:639–650

    Article  PubMed  Google Scholar 

  25. Papadopoulou SL, Girasis C, Dharampal A et al (2013) CT-SYNTAX score: a feasibility and reproducibility Study. JACC Cardiovasc Imaging 6:413–415

    Article  PubMed  Google Scholar 

  26. Peterson ED, Dai D, DeLong ER et al (2010) Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol 55:1923–1932

    Article  PubMed Central  PubMed  Google Scholar 

  27. Ranucci M, Castelvecchio S, Menicanti L et al (2009) Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation 119:3053–3061

    Article  PubMed  Google Scholar 

  28. Wykrzykowska JJ, Garg S, Onuma Y et al (2011) Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‚All-Comers‘ LEADERS trial. Circ Cardiovasc Interv 4:47–56

    Article  CAS  PubMed  Google Scholar 

  29. Weintraub WS, Grau-Sepulveda MV, Weiss JM et al (2012) Comparative effectiveness of revascularization strategies. N Engl J Med 366:1467–1476

    Article  CAS  PubMed  Google Scholar 

  30. Shahian DM, O’Brien SM, Sheng S et al (2012) Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation 125:1491–1500

    Article  PubMed Central  PubMed  Google Scholar 

  31. Weintraub WS, Grau-Sepulveda MV, Weiss JM et al (2012) Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation 125:1501–1510

    Article  PubMed Central  PubMed  Google Scholar 

  32. Graham MM, Knudtson ML, O’Neill BJ, Ross DB (2006) Treating the right patient at the right time: access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery. Can J Cardiol 22:679–683

    Article  PubMed Central  PubMed  Google Scholar 

  33. Sobolev BG, Fradet G, Kuramoto L, Rogula B (2013) The occurrence of adverse events in relation to time after registration for coronary artery bypass surgery: a population-based observational study. J Cardiothorac Surg 8:74

    Article  PubMed Central  PubMed  Google Scholar 

  34. Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003

    Article  PubMed  Google Scholar 

  35. De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001

    Article  Google Scholar 

  36. Tonino PA, De Bruyne B, Pijls NH et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213–224

    Article  CAS  PubMed  Google Scholar 

  37. Pijls NH, Schaardenburgh P van, Manoharan G et al (2007) Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 49:2105–2111

    Article  PubMed  Google Scholar 

  38. Yusuf S, Zucker D, Peduzzi P et al (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344:563–570

    Article  CAS  PubMed  Google Scholar 

  39. Morice MC, Serruys PW, Kappetein AP et al (2010) Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 121:2645–2653

    Article  CAS  PubMed  Google Scholar 

  40. Morice MC, Serruys PW, Kappetein AP et al (2014) Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation 129:2388–2394

    Article  PubMed  Google Scholar 

  41. Farkouh ME, Domanski M, Sleeper LA et al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367:2375–2384

    Article  CAS  PubMed  Google Scholar 

  42. Kappetein AP, Head SJ, Morice MC et al (2013) Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 43:1006–1013

    Article  PubMed  Google Scholar 

  43. Kapur A, Hall RJ, Malik IS et al (2010) Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 55:432–440

    Article  PubMed  Google Scholar 

  44. Stettler C, Allemann S, Wandel S et al (2008) Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 337:a1331

    Article  PubMed Central  PubMed  Google Scholar 

  45. Bangalore S, Kumar S, Fusaro M et al (2012) Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ 345:e5170

    Article  PubMed Central  PubMed  Google Scholar 

  46. Velazquez EJ, Lee KL, Deja MA et al (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364:1607–1616

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Velazquez EJ, Williams JB, Yow E et al (2012) Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. Ann Thorac Surg 93:523–530

    Article  PubMed Central  PubMed  Google Scholar 

  48. Valgimigli M, Campo G, Monti M et al (2012) Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 125:2015–2026

    Article  CAS  PubMed  Google Scholar 

  49. Gwon HC, Hahn JY, Park KW et al (2012) Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation 125:505–513

    Article  CAS  PubMed  Google Scholar 

  50. Kim BK, Hong MK, Shin DH et al (2012) A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol 60:1340–1348

    Article  CAS  PubMed  Google Scholar 

  51. Feres F, Costa RA, Abizaid A et al (2013) Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA 310:2510–2522

    CAS  PubMed  Google Scholar 

  52. Kedhi E, Stone GW, Kereiakes DJ et al (2012) Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials. EuroIntervention 8:599–606

    Article  PubMed  Google Scholar 

  53. Silber S, Kirtane AJ, Belardi JA et al (2014) Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation. Eur Heart J 35:1949–1956

    Article  CAS  PubMed  Google Scholar 

  54. Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093–1100

    Article  PubMed  Google Scholar 

  55. Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999–3054

    Article  PubMed  Google Scholar 

  56. Montalescot G, Bolognese L, Dudek D et al (2013) Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 369:999–1010

    Article  CAS  PubMed  Google Scholar 

  57. Montalescot G, Hof AW van ‚t, Lapostolle F et al (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 371:1016–1027

    CAS  PubMed  Google Scholar 

  58. Montalescot G, Lassen JF, Hamm CW et al (2013) Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study. Am Heart J 165:515–522

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. H. Nef, M. Renker und C.W. Hamm erklären, dass kein Interessenkonflikt besteht.

Dieser Beitrag enthält keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Medizinische Klinik I, Kardiologie und Angiologie, Universitätsklinikum Gießen, Klinikstr. 33, 35392, Gießen, Deutschland

    H. Nef, M. Renker & C.W. Hamm

  2. Abteilung Kardiologie, Kerckhoff-Klinik, Bad Nauheim, Deutschland

    C.W. Hamm

Authors
  1. H. Nef
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Renker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C.W. Hamm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Nef.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nef, H., Renker, M. & Hamm, C. ESC/EACTS-Leitlinie zur Revaskularisation des Myokards. Herz 39, 913–918 (2014). https://doi.org/10.1007/s00059-014-4180-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-014-4180-4

Schlüsselwörter

Keywords

Search

Navigation